iShares Edge MSCI Europe Minimum Volatility UCITS ETF

IMV Inc is a clinical-stage biopharmaceutical company focused on developing immunotherapies. Based in Canada, its primary aim is to create novel treatments for cancer and infectious diseases. The company leverages its proprietary drug delivery platform to achieve this. Operating within the biotechnology sector, IMV Inc specialises in developing a new class of targeted immunotherapies. Its approach aims to generate robust and durable immune responses to specific targets, potentially leading to improved patient outcomes against various diseases. Keep up to date on the latest share price changes by adding IMV stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.